Stephen Rossi

CDO

  • > 25 years experience in clinical development and medical affairs with a focus on metabolic, cholestatic and viral liver diseases
  • PharmD from University of California at San Francisco; Fellowship in Transplant Immunopharmacology
  • Roche Pharmaceuticals, Roche Molecular, Gilead Sciences, NGM Biopharmaceuticals, ,CymaBay Therapeutics, Pliant Therapeutics
  • Program lead for multiple novel clinical candidates in NASH and cholestatic liver disease

Stephen Rossi